The Sleep Apnea Devices market size in the Asia Pacific is forecasted to grow USD 2.52 billion by 2028 from USD 1.73 billion in 2023. This market is estimated to grow at a CAGR of 7.9% during the forecast period. It captures 20% of the global market.
The rising prevalence of sleep apnea cases among the population of APAC region primarily drives the growth of the APAC sleep apnea devices market. Approximately 34 million individuals suffer from obstructive sleep apnea, with 14% of men and 12% of women affected by the disorder in India. Sleep apnea is a sleep disorder characterized by repeated interruptions in breathing during sleep. Common symptoms include loud snoring, morning headaches, insomnia and irritability. The disorder is classified into two types, which are obstructive sleep apnea, caused by upper airway blockage and reduced airflow, and central sleep apnea, which occurs when the brain fails to send proper signals for breathing. Factors such as obesity, enlarged tonsils, and hormonal changes contribute to the development of sleep apnea. Healthcare providers recommend sleep apnea devices as a solution to individuals suffering from the disorder, thereby driving the regional market growth.
The increasing geriatric population and rising awareness about sleep apnea devices drive the growth of the sleep apnea devices market in the Asia-Pacific region. The Asia Pacific region is projected to have one in four individuals aged 60 and above by 2050. With advancing age, the older population is more prone to sleep apnea disorders due to physiological changes in their bodies. Elderly individuals suffering from obstructive sleep apnea often experience a decline in physical and cognitive abilities. They rely on sleep apnea devices to enhance their quality of life, thereby boost the regional market growth.
Advancements in sleep apnea device technologies and innovations, growing focus on the development of home-based sleep apnea devices for patient convenience, increasing number of research and development activities in the sleep apnea device industry and supportive initiatives and campaigns by medical device organizations to promote sleep apnea awareness drive the growth of the APAC market. Favorable reimbursement policies for sleep apnea devices in the APAC region, growing number of collaborations and partnerships between manufacturers and healthcare providers, increasing demand for effective and non-invasive sleep apnea treatment options and rapid adoption of telemedicine and remote monitoring solutions for sleep apnea management boost the growth rate of the APAC market. The growing disposable income, increased healthcare expenditure in the APAC region and rising prevalence of comorbidities associated with sleep apnea, such as obesity and cardiovascular diseases and government initiatives and policies promoting better sleep health and management of sleep disorders further fuel the APAC market growth.
The high cost of devices, the shortage of skilled professionals in manufacturing centers, lack of awareness about the devices and lengthy approval processes for novel devices primarily hinder the APAC market growth. The potential side effects associated with using sleep apnea devices, such as dry mouth, nasal congestion, mask-related irritations and infections is another major obstacle to the regional market growth. The availability of alternative therapies further impedes the market growth.
This research report on the APAC Sleep Apnea Devices Market has been segmented and sub-segmented into the following categories.
By Diagnostic Devices:
By Therapeutic Devices:
The Asia Pacific region had the second largest share of the worldwide market in 2022 and is expected to grow at the fastest CAGR during the forecast period among all the regions. Oral therapies are prominently used for sleep apnea treatment in the region. Key players and healthcare organizations have conducted extensive awareness campaigns and advertisements to boost the demand for sleep apnea devices.
China led the sleep apnea devices market in the Asia-Pacific region in 2022 and is expected to continue showing the domination in the regional market throughout the forecast period. The presence of expanding manufacturing facilities and the development of cost-effective devices drive the growth of the Chinese market. The rapid adoption of m-health and telemedicine for sleep apnea treatment and diagnosis further boost the growth rate of the Chinese market. On the other hand, India and Japan are predicted to account for a considerable share of the APAC market during the forecast period owing to the increasing availability of sleep apnea devices through both online and offline retail channels.
Promising companies leading the Asia Pacific Sleep Apnea Devices Market are ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com